Autolus Therapeutics (AUTL) Interest & Investment Income: 2017-2025
Historic Interest & Investment Income for Autolus Therapeutics (AUTL) over the last 6 years, with Sep 2025 value amounting to $4.4 million.
- Autolus Therapeutics' Interest & Investment Income fell 47.33% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.2 million, marking a year-over-year decrease of 16.90%. This contributed to the annual value of $32.4 million for FY2024, which is 139.58% up from last year.
- According to the latest figures from Q3 2025, Autolus Therapeutics' Interest & Investment Income is $4.4 million, which was down 16.28% from $5.2 million recorded in Q2 2025.
- Over the past 5 years, Autolus Therapeutics' Interest & Investment Income peaked at $28.0 million during Q3 2021, and registered a low of $28,000 during Q1 2022.
- Over the past 3 years, Autolus Therapeutics' median Interest & Investment Income value was $5.2 million (recorded in 2025), while the average stood at $5.6 million.
- In the last 5 years, Autolus Therapeutics' Interest & Investment Income skyrocketed by 75,575.68% in 2021 and then crashed by 99.41% in 2022.
- Over the past 5 years, Autolus Therapeutics' Interest & Investment Income (Quarterly) stood at $149,000 in 2021, then skyrocketed by 857.05% to $1.4 million in 2022, then surged by 111.08% to $3.0 million in 2023, then skyrocketed by 147.41% to $7.4 million in 2024, then plummeted by 47.33% to $4.4 million in 2025.
- Its Interest & Investment Income was $4.4 million in Q3 2025, compared to $5.2 million in Q2 2025 and $6.1 million in Q1 2025.